CEAT Q1: consolidated PAT crashes to ₹4 Cr as RM inflation guts margins; revenue up 22%
PAT -96.44% YoY · revenue +22.35% · margins compressing
₹4,318 Cr
+22.35% YoY
₹4 Cr
-96.44% YoY
0.09%
-3.1pp YoY
₹1.07
CEAT's June-quarter (Q1 FY27) print is a textbook margin-collapse: consolidated revenue rose 22.4% YoY to ₹4,318 Cr on healthy demand and high-capacity utilisation, but consolidated net profit attributable to owners cratered 96% YoY to just ₹4 Cr (from ₹112 Cr) and 98% QoQ (from ₹244 Cr). Net profit margin fell to 0.09% from 3.18% a year ago and 5.78% last quarter, while operating margin compressed to 8.56% (vs 10.94% YoY, 14.18% QoQ). The squeeze sits almost entirely on the cost-of-materials line — consolidated raw-material consumption jumped to ₹2,978 Cr on the 15-20% commodity cost spike management had flagged.
Q1 FY-2027 vs prior quarters
Management's own framing matches the print: MD Arnab Banerjee called Q1 "a challenging quarter," pinning the hit on West Asia-driven raw-material inflation, and CFO Kumar Subbiah confirmed only ~5% cumulative price hikes have been taken so far — below the "up to 10%" staggered increases guided on the Q4 concall — with RM costs expected to stay inflated into Q2. So this quarter validates, rather than contradicts, the cautiously-optimistic near-term guidance: the margin pain was pre-warned, though the depth of the consolidated bottom-line collapse is worse than the standalone caution implied.
The stock went into the print at ₹3,829.6, up 11.8% over the past month of trading.
For context: revenue is at a 6-quarter high.
Management guides for supportive but moderating demand in FY'27, facing significant near-term margin pressure from a 15-20% raw material cost spike in Q1. To counter this, the company is implementing staggered price hikes of up to 10% and will prudently manage capex of INR 1,300-1,400 crores. The long-term strategy rem
— This quarter: met
The headline consolidated number overstates the operating damage: standalone PAT was ₹98 Cr (down a milder 27% YoY from ₹135 Cr, NPM 2.36%), meaning roughly ₹94 Cr of the consolidated shortfall comes from below the parent. Four unreviewed subsidiaries booked a combined ₹79 Cr net loss — largely the CAMSO/OHT business consolidated from Sep 2025 (₹274 Cr equity + ₹719 Cr loan already remitted) and still pre-scale — and a ₹48 Cr forex loss was reclassified to finance costs at OHT Lanka. Readers will see two very different profit figures; the consolidated ₹4 Cr is the group truth, the ₹98 Cr standalone the India tyre core.
What to watch
W1
Pace of price hikes vs the ~5% taken so far — whether the balance of the guided 10% lands in Q2 to rebuild the 8.56% OPM
W2
RM cost trajectory: management expects commodity costs to stay inflated in Q2; watch cost-of-materials as % of revenue (currently ₹2,978 Cr)
W3
CAMSO/OHT subsidiary losses (₹79 Cr this quarter) — CEAT guided revenue benefits in H2 FY27 and margin expansion in FY28; watch the standalone-to-consolidated PAT gap narrow
W4
₹1,205 Cr new capex plus ₹1,300-1,400 Cr FY27 envelope against rising debt (net worth ₹4,991 Cr, D/E 0.65x)
Clean digital filing. Consolidated: PBT ₹32 Cr is 'profit before share of JV and tax'; after tax ₹33 Cr it is −₹1 Cr, +₹5 Cr JV share = ₹4 Cr PAT attributable to owners (non-controlling interest ~₹0). Exceptional items ₹7 Cr (VRS) both periods small. Consol PAT hit hard by subsidiary losses — 4 unreviewed subs posted ₹79 Cr net loss (CAMSO/OHT integration) and note 8 reclassed a ₹48 Cr FX loss to finance costs at a subsidiary. Standalone (₹98 Cr PAT) diverges sharply from consolidated (₹4 Cr).
Revenue +22%, PAT -96% — margin collapse swallows growth
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade C
CAMSO margin degraded from prior 12-13% guidance (now negative); capex reaffirmed; profit guidance missed catastrophically.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Revenue +22% is robust but buried by profit collapse (PAT -96%, consolidated NPM 0.1%). Raw material inflation is 16-18%, price hikes lag at 11%, leaving margins razor-thin. CAMSO is dilutive (negative EBITDA in Q1) and benefits are deferred to H2 FY'27+. Management guided capex ₹1,300-1,400 Cr and reaffirmed demand moderation but expected Q2 margin pressure to persist. Long-term strategy (EV, premiumization, capacity) is sound but near-term execution is poor.
₹4318 Cr
Revenue · +22.3% YoY₹4 Cr
Reported PAT · −96.4% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Strong revenue growth of 18.3% Y-o-Y stand-alone
METStand-alone revenue ₹4,163 Cr, 18.2% YoY growth; consolidated ₹4,318 Cr, 22.3% YoY
Raw material cost increase about 15-16% vs Q4
METCFO confirmed 16-18% surge Q1 vs Q4 in crude and natural rubber; 8-10% further pressure expected Q2
Price hikes of 7-8% replacement, 3-4% OEM by end-Q1
METCFO disclosed cumulative 11% replacement (including July hikes), 5-7% IB, double-digit OEM effective 1 July
CAMSO to return to prior ₹1,000-1,200 Cr revenue with 12-13% margin in FY'28
OVERSTATEDCurrent run rate USD 10M/month (≈USD 120M annualized); negative EBITDA in Q1; only 60% customer transition done by end-Q1
Replacement segment receptive to pricing; demand remains robust in Q1
MISSRevenue growth partly from price (1/3), volume growth (2/3); Q1 margin compressed 575 bps despite 7-8% price hikes, signalling cost still ahead of price
Earnings quality
What changed since the last call
CAMSO margin trajectory
DowngradePrior guidance ₹1,000-1,200 Cr revenue with 12-13% margin now shows negative EBITDA Q1; recovery deferred to H2 FY'27, not imminent
Capex for 2-wheeler capacity
New₹1,205 Cr new capex approved for 53,000 additional 2-wheeler tyres, phased to FY'31; within existing ₹1,300-1,400 Cr FY'27 capex envelope
Q2 demand and margin outlook
NeutralMaintained 'supportive but moderating' demand; explicitly flagged Q2 margin pressure to persist; no numeric margin recovery target given
Price hike quantum
Upgrade11% cumulative replacement price hikes by early July (vs prior 'up to 10%' guidance); further 3-4% planned through August
The Q&A
Analysts pressed hard on CAMSO margin recovery, price hike sustainability vs. demand, and forex loss accounting. Management held firm on pricing but deferred CAMSO profitability to H2/FY'28. No rollback of price hikes contemplated despite margin compression. Tone was defensive on near-term but confident on long-term strategy.
Premium segment market share — Kapil Singh, Nomura
AnsweredOE >20% share in premium EVs, replacement indexed to overall ~13% market share, growing to 30-40% in 5 years
Price hike sufficiency — Kapil Singh, Nomura
AnsweredFurther price hikes needed; taken on 1 July, indexed OEM hikes in place, continuation through July-August
CAMSO FY'28 revenue — Kapil Singh, Nomura
PartialCurrent USD 10M/month run rate (USD 120M annualized); expect growth from there
Price hike vs. cost inflation math — Raghunandhan NL, Nuvama
Answered7-8% moved to 11% already; will take another 4-6% through July-August; competitor table is moving up
CAMSO customer transition & margin — Raghunandhan NL, Nuvama
PartialOne-offs: warehouses, hiring, infra for overseas customer locations (Germany, UK, France, Poland). 90% transition by Sept; gross margin healthy but operating margins negative. Need 1-2 more quarters for clarity.
Natural rubber pricing floor — Vijay Pandey, Axis Capital
DodgedLocal prices move in tandem with international (SICOM); currently at ₹20/kg premium due to supply chain disruptions & low inventory. Cannot forecast floor price impact; Q2 costs 'kind of fixed for us'; hope for correction in later quarters when normalcy returns.
CAMSO historical guidance — Basudeb Banerjee, CLSA
DodgedRun rate USD 10M/month at customer prices (USD 120M annualized); transition period so no change positive/negative. When handling customers in H2, will know what to do with business. Positive about returning to margin level but will take time.
Price hike rollback risk — Joseph George, IIFL
AnsweredPrice hikes lagging cost increases; still inadequate (margins prove it). Competitors taking hikes in different categories/dates; price table moving up. No rollback contemplated at this moment.
Forex loss accounting — Joseph George, IIFL
AnsweredNo offset because rupee-dollar moved minimally Q1; only LKR depreciated (310→335 to $1) without corresponding INR appreciation. Currency exposure in Lanka unhedged; 30% debt being converted to equity per board approval.
Capex guidance & new capacity — Basudeb Banerjee, CLSA
AnsweredWithin ₹1,300-1,400 Cr FY'27 envelope; current-year capex outflow not significant; phased to FY'31
Guidance
FY'27 revenue growth in mid-to-high single digits; demand supportive but moderating
MediumQ1 delivered 22.3% (including CAMSO), 18.2% stand-alone; moderation expected in Q2. Replacement mid-single-digit, OEM mid-to-high single-digit, international strong despite Middle East headwinds.
CAMSO revenue USD 10M/month run rate; growth expected H2 post-customer transition
MediumCurrently USD 120M annualized; no specific FY'28 target, only indication of growth from current base. Deferred to H2 when 90% customer transition complete (vs 60% at Q1-end).
Q2 margin pressure to persist; Q1 gross margin 33.9% vs normal 40-41% levels
HighRaw material costs expected to decline only 8-10% Q2 vs Q1 (vs 16-18% spike); price lag will continue impacting margins. Recovery dependent on raw material normalization + further price realization.
CAMSO margins to expand in FY'28 when operations under full control; H2 FY'27 profit modest
MediumCurrently negative EBITDA in Q1 (startup costs, warehouses, new hires); gross margin 'still healthy' per management. Operating margin recovery depends on 90% customer transition and direct servicing model launch.
FY'27 capex ₹1,300-1,400 Cr (reaffirmed); prioritizing capacity-related over routine capex
HighQ1 capex ₹293 Cr. High capacity utilization across plants. New ₹1,205 Cr 2-wheeler capacity project approved (53,000 tyres, phased to FY'31) within existing envelope.
Risks the call surfaced
Raw material & commodity volatility
HighCrude oil >$100/barrel (April-May average), natural rubber ₹280/kg (15-year high); domestic premium ₹20/kg over international. Cost surge 16-18% Q1; Q2 expected 8-10% more pressure. Price hikes lag by 4-6 percentage points.
Price realization & demand elasticity
HighManagement took 11% cumulative replacement price hikes but margins still compressed 575 bps QoQ. Q2 moderation expected. If demand proves elastic (volume declines >5% on pricing), margin recovery will be delayed. Competitor responses vary by category.
CAMSO integration execution
HighOnly 60% customer transition by end-Q1; 90% expected by Sept (Q2-end). Currently EBITDA negative due to startup costs (warehouses, hires, offices in 5 countries) without matching revenue (Michelin still handling sales, CEAT gets only partial realization). Margin recovery to 12-13% pushed to FY'28, vague timeline.
Currency exposure in Sri Lanka
HighLKR depreciated from ₹310-315/$1 to ₹335/$1 in Q1, triggering ₹48 Cr MTM loss (non-cash but impacting consolidated PAT). LKR historical range pre-crisis ₹185-190/$1; post-crisis fluctuation to ₹370-380/$1. Cannot be hedged; structural risk.
Demand moderation & rural vulnerability
MediumManagement explicitly warned 'moderation in demand may happen in Q2' but expects demand not to 'fall off cliff'. El Niño poses risk to rural demand via reduced farm incomes. West Asia geopolitical disruption affecting supply chains and international sales. Replacement expected only mid-single-digit growth.
Management
Score 7/10. Transparent on raw material dynamics and pricing mechanics; technical depth on forex loss and CAMSO transition. Evasive on CAMSO margin recovery path and specific FY'28 targets. Held firm on pricing strategy despite margin pain. Capex guidance met (₹293 Cr Q1 on ₹1,300-1,400 Cr FY'27 plan); CAMSO transition 60% done on schedule; price hikes aggressive (11%). But consolidated PAT collapsed 96%, missing implicit profit guidance. Margin compression worse than 'significant pressure' language suggested.
1 · Q2 FY27 (Sep 2026)
CAMSO customer transition 90% complete; 53k 2-wheeler capacity project board-approved (₹1,205 Cr capex phased to FY'31)
2 · H2 FY27 (Oct 2026+)
CAMSO direct customer handling begins; margin recovery from value-chain control; raw material cost pass-through expected
3 · FY'28 (Apr 2027+)
CAMSO full operational independence; margin expansion to 12-13% as guided; replacement demand visibility improves
Long-term strategy (EV, premiumization, capacity) is sound but near-term execution is poor.
Revenue surges, profit implodes—the margin lag will define FY'27
Consolidated PAT collapsed 96% despite 22% revenue growth. The gap between headline and profit is raw material inflation outrunning price hikes—a dynamic that will frame the full year.
₹4 Cr
-96.4% YoY
₹98 Cr
-27% QoQ
33.9%
-575 bps QoQ vs normal 40–41%
11%
Cumulative through early July
On the surface, a revenue print of ₹4,318 crore at 22.3% YoY looks robust. Dig into profit, and the quarter fractures. Consolidated PAT of ₹4 crore is not a typo — it's the net effect of stand-alone profit of ₹98 crore, erased by a ₹48-crore forex loss (CAMSO subsidiary LKR depreciation) and CAMSO's negative operating margins during its customer-transition phase. Even the stand-alone number tells a hard story: down 27% quarter-on-quarter despite revenue up 2.3% QoQ. This is a margin tale, not a growth tale.
Where the profit went
Consolidated profit of ₹4 crore masks a real operational issue: stand-alone PAT of ₹98 crore still declined quarter-on-quarter. The gap comes from two forces. First, the Sri Lanka subsidiary's LKR depreciated from ₹310–315/$1 to ₹335/$1, triggering a ₹48-crore mark-to-market loss on an $80-million parent loan — this is non-cash but dents consolidated earnings. Second, CAMSO carries negative EBITDA in Q1 as it ramps transition costs (warehouses, hiring, new offices in Germany, UK, France, Poland) ahead of revenue realization; only 60% of customer handover is complete. The operating margin on stand-alone CEAT fell to 9.1% from prior 10%+ levels, and gross margin compressed 575 basis points to 33.9%, signaling raw material cost is still running ahead of price realization.
Raw material costs surged in high teens, in the range of about 16% to 18% in quarter 1 compared to quarter 4.
Strong revenue growth +22% (consolidated) on volume momentum
18.2% stand-alone YoY; 2/3 from volume growth, 1/3 from price/mix
Supported
Raw material cost spike 15–16% Q1 vs Q4
CFO confirmed 16–18% surge in crude and natural rubber; natural rubber at ₹280/kg (15-year high)
Supported
Price hikes of 7–8% replacement and 3–4% OEM by end-Q1
Cumulative 11% replacement hikes by early July (including July increments); 5–7% IB, double-digit OEM effective 1 July
Upgraded but insufficient
CAMSO will return to prior guidance of ₹1,000–1,200 Cr revenue with 12–13% margin in FY'28
Current run rate USD 10M/month (≈USD 120M annualized); Q1 EBITDA negative from transition costs; only 60% customer handover at Q1-end; no new quantified FY'28 margin target
Overstated; recovery timeline vague
Replacement segment demand remains robust despite pricing
Gross margin down 575 bps QoQ despite 7–8% price hikes Q1; implies raw material cost still ahead of price realization
Contradicted by margin compression
What changed on this call
CAMSO margin trajectory downgraded. Prior FY'26 calls guided to ₹1,000–1,200 crore revenue with 12–13% margin by FY'28. The Q1 reality: negative EBITDA, 60% transition done, and recovery deferred to H2 FY'27 onward with no new margin target. This is an implicit downgrade, though management framed it as 'part of the plan; we will know more post-transition.' New capex for 2-wheeler capacity announced. Board approved a ₹1,205-crore capex for 53,000 additional 2-wheeler-tyre capacity, phased through FY'31. This sits within the existing ₹1,300–1,400 crore FY'27 capex envelope, so no fresh ask, but it signals capital intensity remains high and benefits are multi-year. Q2 margin pressure explicitly flagged. Management reiterated 'supportive but moderating' demand for FY'27, but openly flagged that Q2 margin pressure will persist—8–10% more raw material cost expected in Q2. This is rare transparency on a negative; the company is preparing street for another difficult quarter. Price hike quantum upgraded. Early signals were 'up to 10%' in cumulative hikes. The Q1 call disclosed 11% replacement hikes by early July, with a further 3–4% planned through August. Replacement segment is holding pricing so far, but demand elasticity remains an open question.
How the street is positioned
The market's reaction was swift and has held firm. The stock fell 7.3% on day 1 post-result, 11.01% by day 3, and 12.67% by day 5—a -₹224 move from the pre-result close of ₹3,829.6. At ₹3,605.4 as of this report, the selloff has stabilized but not reversed. The stock sits above its 50-day and 200-day moving averages (₹3,567 and ₹3,641 respectively) but 14% below its all-time high, signaling a re-rating rather than a panic. Notably, FII trimmed by 2.73 percentage points to 13.82%, while DII added 1.31 percentage points to 22.20%—foreign money is exiting, domestic money is buying weakness. This divergence suggests Indian institutions see value, but global money is waiting for margin recovery evidence.
Revenue +22% is genuine; volume growth +13–14% YoY, price 1/3 of the mix
Long-term strategy intact: EV share 25% (OEM), premium segment +100% (replacement), capacity expansion ₹1,205 Cr phased
Replacement pricing holding: 11% cumulative hikes, no rollback contemplated, competitors following (though timing varies)
Consolidated PAT ₹4 Cr is a 96% collapse; stand-alone down 27% QoQ despite 2.3% revenue growth
Gross margin 33.9% vs normal 40–41%; -575 bps QoQ despite price hikes means cost still winning
CAMSO negative EBITDA Q1; margin guidance (12–13% FY'28) now implicit downgrade with no new target
Currency exposure unhedged: ₹48 Cr MTM loss on LKR/$1 in Q1; structural risk in Lanka subsidiary
Q2 margin pressure explicitly flagged; management flagged 8–10% more raw material cost expected
Demand moderation underway; Q1 beat implied guidance at +22%, but Q2 'support but moderation' expected
Raw material volatility unresolved
HighCrude >$100/bbl, natural rubber ₹280/kg (15-yr high). Q1 cost surge 16–18%, Q2 expected 8–10% more. Price lags by 5–7 percentage points. If commodities stay elevated through H2, margin recovery is pushed to FY'28, delaying credibility reset.
Price hike absorption risk
High11% replacement hikes holding so far, but demand elasticity untested at this magnitude. If volume growth inflects negative >5% due to pricing, market share erosion could offset margin gains. Competitor responses vary by category; no unified price table.
CAMSO integration execution
HighOnly 60% customer transition by Q1-end; 90% target Sept Q2-end. Currently EBITDA-negative from startup costs (warehouses, hires, offices in 5 countries). If transition slips or margin recovery delays beyond H2, FY'28 targets miss and multiples compress further.
Currency exposure (Sri Lanka unhedged)
HighLKR depreciated 310→335/$1 in Q1, triggering ₹48 Cr MTM loss. Structural risk; LKR has ranged 185–190 pre-crisis to 370–380 post-crisis. No hedging possible in Lankan rupee economy. $24.5M debt-to-equity conversion approved but downside remains. Future quarters could see further ₹30–50 Cr losses if LKR weakens more.
Demand moderation in Q2–Q3
MediumManagement flagged moderation but not 'cliff.' Replacement expected mid-single-digit growth (vs 22% YoY consolidated Q1). Rural demand vulnerable to El Niño/monsoon deficit. Geopolitical disruption in Middle East (15–20% of international revenue) persists. If demand rolls over faster than cost normalizes, margin recovery timeline extends.
1 · Q2 gross margin recovery signal
Management expects 8–10% raw material cost pressure in Q2 (vs 16–18% in Q1). If gross margin rebounds toward 37–38%, cost inflation is normalizing and price lags will compress. If it stays <36%, the margin story remains broken and near-term recovery evaporates. Track the absolute gross margin and the QoQ delta.
2 · CAMSO customer transition & first direct-servicing month
90% transition expected by Sept Q2-end. Watch for the first full month of CEAT handling customers directly in H2 (Oct onwards). Management should disclose gross margin on direct customer revenue (vs. current Michelin pass-through model) and a revised operating-margin path to FY'28. Vague language here is a red flag; concrete numbers needed.
3 · Price realization in replacement segment
Volume vs. price/mix breakdown for Q2 is critical. If volume growth stays +10%+, pricing power is intact and Q2 can beat cautious guidance. If volume inflects to low-single-digit or negative, demand elasticity is biting and rollback risk rises. This is the market's biggest debate; management's answer in Q2 will re-rate the stock.
CEAT is not broken. Revenue growth of 22% is real, driven by 13–14% volume and sustained pricing. The long-term strategy—EV penetration, premiumization, capacity expansion—is intact and being executed. But the Q1 quarter is a story of margin lag: raw material costs ran 16–18% ahead while prices rose 11%, leaving gross margin down 575 basis points. The consolidated PAT of ₹4 crore is a headline shock (96% decline), but stand-alone profit of ₹98 crore down 27% QoQ is the real operational issue. CAMSO is dilutive, and currency losses ($80M LKR-denominated loan unhedged) are structural.
The stock is repriced 12% lower from the announcement and 14% below its all-time high. FII is exiting; DII is buying weakness. That divergence reflects the debate: Indian institutions see long-term value, but global money is waiting for near-term margin recovery evidence. The verdict is Hold. Not a sell (thesis intact), not a buy (execution poor). Q2 will be critical: if gross margin bounces toward 37–38% and CAMSO transition progresses, the narrative flips from 'margin lag' to 'cyclical trough.' If margin stays compressed and CAMSO slips, the re-rating could deepen.
The number to track from here is organic PAT (stand-alone, ex-forex): it's your proxy for core margin recovery. Down 27% QoQ is a harder story than revenue growth suggests. Await Q2 results in late October; that's when the FY'27 margin path becomes clear.